Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-060754

CBO & EVP sold 286 shares at $81.14 ($23,206)

From the SEC's structured data for this filing

Trades in this filing

Kassberg Thomas Richard · CBO & EVP

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-10-14 Sale : show line 1 in the form −286 $81.14 $23,206 216,266 D
Open-market sales · 286 sh · avg $81.14 · $23,206
Loading xslF345X03/doc4.xml…